฿78.52
+฿0.42(+0.53%)
data.updated
v2.stock.overview v2.daily.trading v2.range.52w
key.stats
yesterday.close฿78.15
market.size฿100.91B
volume.trade5.41M
pe.ratio23.20
div.yield3.61%
div.amount฿0.71
diluted.eps3.59
net.income฿4.66B
revenue฿33.53B
earnings.date2026-06-03
eps.estimate1.57
rev.estimate฿9.62B
shares.out1.29B
beta0.632
ex.div.date2026-03-27
div.pay.date2026-04-17
about.stock
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
sectorHealthcare
industryMedical - Devices
ceoGeoffrey Straub Martha
headquartersGalway,None,IE
websitehttps://www.medtronic.com
employees95.00K
avg.revenue฿353.02K
income.per.emp฿49.07K
เรียนรู้เพิ่มเติมเกี่ยวกับ Medtronic plc (MDT)
learn.articles
MDT Decentralized Data Platform: Transforming the Data Economy with BlockchainMDT (Measurable Data Token) centers on a decentralized data exchange protocol, leveraging the Ethereum blockchain and ERC-20 tokens to create a secure, transparent, and equitable data trading ecosystem.2025-12-10

2025 Q3 Measurable Data Token (MDT) Price Forecast: Short-Term Trend AnalysisDiscover short-term price forecasts for Measurable Data Token (MDT) in Q3 2025. By integrating recent platform upgrades with technical analysis, this guide helps newcomers identify and capitalize on short-term investment opportunities.2025-07-30

Gate Research: Ethereum DEX trading volume reached a new all-time high in August | Bonk.fun named the official Launchpad for USD1Gate Research: On September 1, BTC encountered resistance at $113,469 and quickly retreated, briefly dipped below $108,000. Following a rally to $4,646, ETH experienced selling pressure and fell to a low of $4,257. In August, Ethereum's DEX trading volume surpassed $140.1 billion, setting a new monthly record. Bonk.fun has entered into a partnership with WLFI, making it the official Launchpad for USD1 on Solana. Japan Post Bank announced plans to launch its own digital currency and support trading of blockchain-based products in 2026.2025-09-01

stock.faq
stock.price
x
current.stats
52w.range.q
x
pe.ratio.q
x
market.cap.q
x
eps.recent.q
x
buy.sell.q
x
price.factors
x
buy.how
x
risk.warn
risk.notice
disclaimer2
risk.disclosure

















































































































































































































































































































































































































































